Fellowship · Burlington, MA
Sponsored by Lahey Clinic
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
The New England journal of medicine · 2023 · 607 citations · Ioana Preston
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.
The New England journal of medicine · 2025 · 121 citations · Ioana Preston
Sotatercept for the Treatment of Pulmonary Arterial Hypertension.
The New England journal of medicine · 2021 · 506 citations · Ioana Preston
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension.
The European respiratory journal · 2023 · 135 citations · Ioana Preston
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
The New England journal of medicine · 2025 · 51 citations · Ioana Preston
A long-term follow-up study of sotatercept for treatment of pulmonary arterial hypertension: interim results of SOTERIA.
The European respiratory journal · 2025 · 44 citations · Ioana Preston
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial.
The European respiratory journal · 2023 · 97 citations · Ioana Preston
Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association.
Circulation · 2023 · 89 citations · Ioana Preston